Live Attenuated Influenza Vaccine as a Nasal Model for Influenza Infection
Clinical trial NCT04164212 · COMPLETED
Trial details
- NCT number
- NCT04164212
- Sponsor
- University of Alabama at Birmingham
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-01
- Primary completion
- 2026-01-22
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.